Aurobindo Pharma Ltd
Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:	524804	NSE Symbol:	AUROPHARMA	P/E :	37.03
ISIN Demat:	INE406A01037	Div & Yield %:	0.24	EPS :	44.86
Book Value:	391.14	Market Cap (Rs. Cr.):	96,471.15	Face Value :	1

Date	Headline
05-Aug-26	Aurobindo Pharma to merge subsidiaries, streamlining operations and creating synergy benefits
03-Aug-26	Aurobindo Pharma receives assurance on its BRSR, confirming adherence to SEBI guidelines
28-Jul-26	Aurobindo Pharma to conduct board meeting
10-Jul-26	Aurobindo Pharma announces incorporation of subsidiary in Indonesia
02-Jul-26	Aurobindo Pharma completes transfer of its branded generic products biz to Auropharm
30-Jun-26	Aurobindo Pharma USA Inc. completes acquisition of Lannett
27-Jun-26	USFDA inspects Auroactive Pharma's manufacturing unit in Andhra Pradesh
22-Jun-26	Aurobindo Pharma USA receives US FTC approval for acquisition of Lannett
19-Jun-26	Aurobindo Pharma receives US FTC approval for acquisition of Lannett business
04-Jun-26	Aurobindo Pharma receives USFDA approval for Tofacitinib Tablets

Company Snapshot